Thrombosis and severe acute respiratory syndrome coronavirus 2 vaccines: vaccine-induced immune thrombotic thrombocytopenia
The development of vaccines against severe acute respiratory syndrome coronavirus 2, which features high mortality and morbidity rates, has progressed at an unprecedented rate, and vaccines are currently in use worldwide. Thrombotic events after vaccination are accompanied by thrombocytopenia, and t...
Saved in:
Main Author: | Young Shil Park (Author) |
---|---|
Format: | Book |
Published: |
The Korean Pediatric Society,
2021-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
COVID-19 vaccine-induced immune thrombotic thrombocytopenia
by: A. B. Sugraliyev, et al.
Published: (2022) -
Most cases of Thrombosis and Thrombocytopenia Syndrome (TTS) post ChAdOx-1 nCov-19 are Vaccine-induced Immune Thrombotic Thrombocytopenia (VITT)
by: Michael Makris, et al.
Published: (2022) -
Vaccine-induced immune thrombotic thrombocytopenia: definition, risks with different vaccines, and regulatory responses
by: S. V. Akinshina, et al.
Published: (2021) -
Recommendations for the diagnosis and management of persons with suspected vaccine-induced immune thrombotic thrombocytopenia (VITT)
by: Nancy Yomayusa
Published: (2021) -
A Case of COVID-19 Vaccine-Induced Thrombotic Thrombocytopenia
by: Abhinandan Chittal, et al.
Published: (2021)